Global Epigenetics Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Epigenetics Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Product (Instruments, Reagents & Kits, and Others), Application (Oncology, Autoimmune Diseases, Metabolic Diseases, CNS/Pain Diseases, Cardiovascular Diseases, and Others), Technology (Methylation, Acetylation, Phosphorylation, and Other Technologies), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Epigenetics Market was valued at USD 14,780.7 million in 2023 and is expected to reach USD 45,529.9 million by 2031 while growing at a CAGR of 15.1% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global epigenetics market growth. Epigenetics involves studying heritable changes in gene function without altering the DNA sequence. It focuses on modifications in DNA structure or associated proteins, influencing gene activity without changing the DNA sequence. These reversible modifications play a crucial role in regulating gene expression, distinct from the genetic code.
The increasing prevalence of chronic diseases and technological advancements in epigenetic research are anticipated to drive the growth of the epigenetics market. However, challenges such as the high costs of epigenetic research and treatment, along with ethical and legal concerns, may impede market expansion.
Furthermore, the global epigenetics industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Product Analysis
The Global Epigenetics Market is segmented among Instruments, Reagents & Kits, and Others, based on Product. In 2023, Instruments accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Application Analysis
The Global Epigenetics Market is segmented among Oncology, Autoimmune Diseases, Metabolic Diseases, CNS/Pain Diseases, Cardiovascular Diseases, and Others, based on Application. In 2023, Oncology accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Epigenetics Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Abcam PLC, Active Motiff, Hologic Inc (Diagenode Inc.), F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Qiagen NV, Thermo Fisher Scientific, Zymo Research Corporation, Perkin Elmer, and Bio-Rad Laboratories.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Epigenetics Market Dynamics
Drivers
Restraints
Opportunity
4. Global Epigenetics Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Epigenetics Market Segmentation, By Product
Global Epigenetics Market Share Analysis, By Product
Global Epigenetics Market Growth Analysis, By Product
Global Epigenetics Market Trends, By Product
o Instruments
o Reagents & Kits
o Others
6. Global Epigenetics Market Segmentation, By Application
Global Epigenetics Market Share Analysis, By Application
Global Epigenetics Market Growth Analysis, By Application
Global Epigenetics Market Trends, By Application
o Oncology
o Autoimmune Diseases
o Metabolic Diseases
o CNS/Pain Diseases
o Cardiovascular Diseases
o Others
7. Global Epigenetics Market Segmentation, By Technology
Global Epigenetics Market Share Analysis, By Technology
Global Epigenetics Market Growth Analysis, By Technology
Global Epigenetics Market Trends, By Technology
o Methylation
o Acetylation
o Phosphorylation
o Other Technologies
8. Global Epigenetics Market Segmentation, By Region
Global Epigenetics Market Share Analysis, By Region
Global Epigenetics Market Growth Analysis, By Region
Global Epigenetics Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
9. Competitive Landscape
Abcam PLC*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Active Motif
Hologic Inc (Diagenode Inc.)
F. Hoffmann-La Roche Ltd
Merck & Co. Inc.
Qiagen NV
Thermo Fisher Scientific
Zymo Research Corporation
Perkin Elmer
Bio-Rad Laboratories
*Similar analysis will be provided for each company listed above.